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The postoperative results in this study show the range of responses to surgery of patients with chronic retention. Patients with low-pressure filling and inadequate detrusor contraction during voiding respond least well. After prostatic surgery they still complain of a slow stream, hesitancy, and a feeling of incomplete emptying. When closely questioned they also often admit to having to strain to void. Their postoperative symptoms, however, suggest residual obstruction. If urodynamic investigations are not used to investigate postprostatectomy symptoms such as these persistent obstruction may be diagnosed. In a previous study several such patients were seen. Some had a second operation, which invariably failed to help them and in five cases led to the development of stress incontinence, presumably due to impairment of the continence mechanisms at and immediately proximal to the external sphincter.
Several operations that aim to improve bladder emptying by decreasing bladder volume-namely, partial cystectomy, vesicoplication, and cystoplasty-have been described-but have been little used in our area. Vesicoplication yields disappointing results and is now rarely performed. Urodynamic studies after vesicoplication in six patients showed a persistently high residual urine and little change in the symptoms. This study has served to define the types of chronic retention found in men and show that urodynamic investigations predict which patients are likely to benefit from prostatectomy. Postoperative urodynamic studies indicate whether the obstruction has been relieved or still persists; they may also explain any persistent postoperative symptoms the patient might have and indicate whether further surgical intervention is warranted. Patients' usual alcohol consumption should be taken into account in determining their acetylator status.
Introduction
The acute interaction between ethanol and drugs usually leads to a decreased rate of drug metabolism. Both oxidation and conjugation of drugs with glucuronic acid, for example, may be inhibited by ethanol.'-, Theoretically, however, ethanol could have the opposite effect on drug acetylation and enhance the speed of this conjugation reaction: ethanol is metabolised to yield acetate9 " and may increase the concentration of acetyl coenzyme A (CoA),11 the acetate donor in the N-acetyltransferase reaction leading to acetylation of drugs.12 If a low concentration of acetyl CoA is rate-limiting in this reaction ethanol metabolism may increase the velocity by enhancing the formation of acetyl CoA. We decided to test this hypothesis. The activity of Nacetyltransferase, which catalyses the transfer of acetyl groups to drugs such as hydrallazine, isoniazid, procainamide, and certain sulphonamides, is under genetic polymorphic control, and people may be classified as slow or rapid acetylators.'3 Sulphadimidine is regarded as a model substance for acetylation, and we therefore used it in our studies.
Materials and methods

IN-VIVO STUDIES ON MAN
Sixteen healthy drug-free volunteers (6 women, 10 men) aged 18-36 years took part in a cross-over study. They were fasted overnight and at 8 am received sulphadimidine by mouth (10 mg/kg). Two hours later they had a light breakfast, normal meals being allowed thereafter. Half the subjects received no further treatment, while the others had ethanol (20) , v/v in fruit juice, 0 73 g,/kg) two hours after taking the drug followed by hourly drinks of 0 11 g,/kg until 10 hours after the drug. Venous blood samples (10 ml) in heparinised tubes and occasionally urine samples were collected at two, four, six, eight, and 10 hours for measurement of drug, ethanol, and acetate concentrations. After centrifugation plasma was stored at -20'C until analysed. One week later the experiment was repeated, the ethanol-treated and control groups being reversed. Thus each subject served as his or her own control.
IN-VITRO STUDIES ON ISOLATED RAT LIVER CELLS
Primary suspensions of isolated rat liver cells were prepared as described. 4 logarithmic scale against time after administration. The "best-fit" straight line was drawn and the half life measured graphically. Renal drug clearance was calculated as the mean of clearances over the four-to-six-hour and six-to-eight-hour periods. Urinary excretion during each period was divided by the mean plasma concentration for that period calculated from the individual semilogarithmic plots of drug concentration.
Results obtained for each individual or cell suspension in the presence of ethanol were compared with results obtained without ethanol by Wilcoxon's test for paired samples. All results are given as means ± SE.
Results
IN-VIVO STUDIES ON MAN
Wide variations in rates of sulphadimidine metabolism were found among the 16 volunteers, nine of whom were classified as rapid acetylators and seven as slow acetylators." Individual sulphadimidine concentrations reached maximum values after two hours and then declined linearly in both the presence and the absence of ethanol. After they had taken ethanol the apparent half life of sulphadimidine decreased by about 20% in both the rapid and the slow acetylators (table I) . This occurred in all participants except one, in whom no change was found. Ethanol administration was followed by relatively constant blood ethanol (about 1 g/l) and acetate (about 0-8 mmol/l; 4-7 mg/100 ml) concentrations from two hours after intake (four hours after sulphadimidine) to the end of the experiment (fig 1) .
The amount of sulphadimidine acetylated in blood increased with time in all experiments (table II). In the controls the increase in percentage acetylation between two and eight hours was 14 7 and 35-3 in the slow and rapid acetylators respectively (table II) . These increases were greater (P <0001) when ethanol was present (19 6% and 44 5%-table II). In three slow acetylators the percentage acetylation measured in blood at eight hours was increased so noticeably after ethanol that they would have been classified as rapid acetylators according to the criteria of Evans.13 The percentage acetylation measured in urine over the first eight hours of the experiment increased in the presence of ethanol by a mean of 13 3 in three subjects.
Ethanol did not change renal sulphadimidine clearance in three subjects (11-42±3 73 ml/min without ethanol, 12 29±3 79 ml/min with ethanol), in whom the apparent sulphadimidine half lives were reduced by an average of 24-1 %/.
There were large variations between individuals in blood acetate concentrations after ethanol. When the mean concentration measured between four and 10 hours was plotted against the part of the increase in the amount of acetylated sulphadimidine that could be ascribed to ethanol (fig 2) some correlation was found (r = 0 49), which bordered on significance at the 5%, level. An even poorer correlation (r= 09) was observed when the mean acetate concentrations were plotted against the relative decreases in apparent sulphadimidine half lives.
IN-VITRO STUDIES ON ISOLATED RAT LIVER CELLS
Ethanol (2 g/l) decreased the half life of sulphadimidine in the primary suspensions of isolated rat liver cells by some 32°, (fig 3) . This could not be explained by increased binding to liver cells of unmetabolised drug, since the administration of ethanol did not influence the recovery of "total" sulphadimidine (metabolised plus unmetabolised) in the samples. 
Discussion
Our results show that acute ethanol intake is accompanied by a decrease in the apparent half life of sulphadimidine and by an increase in the amount of acetylated sulphadimidine in blood and urine. The individual plasma concentration curves (not shown) excluded any appreciable effect of ethanol on sulphadimidine absorption and distribution. Increased renal excretion of sulphadimidine after ethanol-due to alcohol diuresis, for example-was not found. These observations were all consistent with the view that ethanol increased the rate of drug acetylation.
The findings were supported by experiments on suspensions of isolated rat liver cells. In this system the sulphadimidine concentration could decrease by metabolism only. As shown in fig 3, ethanol decreased the apparent half life of sulphadimidine in the liver cell suspensions. The precise mechanism is speculative. The magnitude of the correlation between blood acetate concentrations and the relative change in sulphadimidine acetylation may argue against a simple relation between ethanol oxidation and drug acetylation. On the other hand, the hepatic concentration of acetyl CoA may be relevant. Since we cannot measure acetyl CoA concentrations in the intact liver further in-vitro experiments are being carried out to clarify the mechanism underlying the effect of ethanol on sulphadimidine acetylation.
To our knowledge this is the first report of this type of interaction between ethanol and sulphadimidine acetylation. In a previous study the metabolism of sulphanilamide in rats appeared to be unchanged by ethanol. 20 In that study, however, drug and metabolites were measured only in urine and sulphanilamide half life was not measured. Furthermore, the mode of administration of drug and alcohol differed appreciably from that in our series. In a study on rats given isoniazid the excretion of N-acetylisoniazid increased in the presence of ethanol.2' In another study the half life of isoniazid was decreased in the presence of ethanol in two test subjects.22 Since sulphadimidine is regarded as a model substance, acetylation of other drugs (isoniazid, hydrallazine, procainamide), and indeed other exogenous compounds, may also be influenced by ethanol. If so, ethanol consumption might reduce blood concentrations of drugs that are metabolised by acetylation. Furthermore, the pattern of metabolites could change noticeably for drugs with alternative metabolic pathways. In such cases ethanol might reduce drug oxidation and glucuronidation but increase acetylation. One might also speculate whether ethanol could increase the toxicity of foreign compounds, since this may be linked to the rate of acetylation. 2' Finally, it may be important to take a patient's usual alcohol consumption into account in determining his acetylator status.
